Progestin Therapy in Endometriosis
نویسندگان
چکیده
منابع مشابه
Progestin therapy in endometriosis.
Progestins are synthetic compounds that mimic the effects of progesteron. For over 50 years, oral progestins have been demonstrated to be effective in the treatment of endometriosis. They were reported to reduce or eliminate pain symptoms in approximately 90% of the patients. Progestins are available in many forms, including oral preparations, injections, subdermal implants and intrauterine sys...
متن کاملEstrogen-progestin replacement therapy and endometrial cancer.
BACKGROUND It has been known for more than 20 years that estrogen replacement therapy substantially increases a woman's risk of developing endometrial cancer. To reduce this increased risk, progestins have been added to estrogen replacement therapy for between 5 and 15 days (usually 7 or 10 days) per "month" in a sequential fashion (sequential estrogen-progestin replacement therapy) or with eac...
متن کاملProgestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
Progestin preparations are made of synthetic progesterone and have often been used for hormone therapy in gynecological patients with endometriosis or endometrial cancer. Hormone therapy using progestin is considered to be one of the effective means of treatment particularly when dealing with endometrial cancer (an estrogen-dependent tumor). Numer...
متن کاملTransdermal progesterone cream as an alternative progestin in hormone therapy.
OBJECTIVE To evaluate the endometrial effects and determine patients' acceptance of transdermal progresterone cream compared to standard hormone therapy. METHODS Healthy menopausal women were recruited and received a pretreatment endometrial biopsy (EMB). They were randomized to 0.625 mg conjugated equine estrogen (CEE) daily and 2.5 mg medroxyprogesterone acetate (MPA) (Prempro, Wyeth USA) o...
متن کاملProgestin therapy of breast cancer: comparison of agents.
We report an analysis of 3,243 cases of squint examined at a health department clinic and an eye hospital. The estimated prevalence of squint at the age of 6 years is 4.3%, similar to estimates in other surveys in England. Incidence of onset is highest in the third year of life, and, if this distribution reflects the incidence in the community, it represents one characteristic pattern of distri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Women's Health
سال: 2015
ISSN: 1745-5065,1745-5065
DOI: 10.2217/whe.15.42